Neuroscience News

Academic leaders debated the future of the intersecting study of natural and artificial intelligence at Wu Tsai Neuro’s Annual Symposium

Join us as we look back on some of the key studies we covered here at Wu Tsai Neuro in 2024 to give a (very partial) overview of the impact of our community’s research efforts this past year

Alice Ting and colleagues have built a new synthetic receptor with  broad potential to program cell activity, including immune response and neurological

This week on the podcast, Stanford neurobiologist Robert Sapolsky lays out his view that we should stop judging one another (and ourselves) for behaviors we can't control

New research from the Malenka lab reveals that reward-based learning requires the two neuromodulators to balance one another's influence.

New research shows aging is not a uniform process. Parts of our bodies start aging earlier than others, right down to our organs and cells.

Fat-filled microglia may play a role in the damage caused by Alzheimer’s, especially for those who carry two copies a particular gene.

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

How early cognitive research funded by the NSF paved the way for today’s AI breakthroughs—and how AI is now inspiring new understandings of the human mind.

With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism.

Today, we are going back into the archives for a conversation with neuroscientist, entrepreneur, and best-selling author David Eagleman about the science of synesthesia. If you don't know what that is, you're about to find out.

Bioengineers and neuroscientists at the Wu Tsai Neurosciences Institute at Stanford University have developed a highly sensitive tool for detecting brain cells’ subtlest electrical signals.

Science Corporation's retinal implant, built on the research of faculty affiliate Daniel Palanker, has allowed some people who lost their central vision to r

This week, we talk with our founding director, Bill Newsome, about the 10-year legacy of the NIH BRAIN Initiative and the uncertainty for the future brought on by this year's dramatic funding cuts.

This week we are talking with Stanford neuroscientist Ivan Soltesz about endocannabinoids, illuminating the "day job" of these unusual neurotransmitters and how they may be hijacked by cannabinoid drugs such as THC and CBD.

Supported by the Big Ideas in Neuroscience program, research from the Brunet lab suggests the possibility of designing pharmaceutical or genetic therapies to turn on new neuron production in old or injured brains.